All In MedTech

FDA Clearance Tracker · P170019-S056

FoundationOneCDx (F1CDx)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 19, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P170019-S056
Device name
FoundationOneCDx (F1CDx)
Applicant location
Boston, MA
Received
Jun 24, 2024
Decided
Dec 19, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P170019

Device type

Device class
Class III

Every decision under product code PQP

FDA's approval statement

As written in FDA's record.

Approval for updates to the Technical Information document for F1CDx.

Source documents

Other decisions for Foundation Medicine, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.